340B Drug Pricing Program: An Updated ASCO Policy Statement
- 5 May 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 22 (9) , 1490-1497
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Minnesota Law Brings Transparency to the 340B Drug Pricing ProgramJAMA Health Forum, 2025
- US Hospital Service Availability and New 340B Program ParticipationJAMA Health Forum, 2024
- The Policy Alliance Between Hospitals and Debt Collection Agencies: Content Analysis of Public Comments on Regulations on Billing and CollectionsINQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2024
- Disentangling the Cost of Orphan Drugs Marketed in the United StatesHealthcare, 2023
- Analysis Suggests Government And Nonprofit Hospitals’ Charity Care Is Not Aligned With Their Favorable Tax TreatmentHealth Affairs, 2021
- Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical OncologyJournal of Oncology Practice, 2014